Eigene klinische Studien

  • HICARE: Hautveränderungen bei Patienten mit Kopf-Hals-Tumoren unter kombinierter RadioImmuno-(chemo)-Therapie mit Erbitux
  • AMOTE: Use of a pretherapeutic and postoperative assessment in elderly patients with locally advanced rectal cancer and decision making process regarding participation in clinical trials – motivation of members of the study team and patients
  • LUX 2: A randomized, double-blind, placebo-controled, phase III study to evaluate the efficacy and safety of afatinib (BIBW 2992) as adjuvant therapy after chemo-radiotherapy in primary unresected HPV negative patients with stage III, Iva of Ivb loco-regionally advanced head and neck squamous cell carcinoma
  • LEOPARDII: definitve radiochemotherapy with 5-FU / Cisplatin plus/minus cetuximab in unresectable locally advanced esophageal cancer, a phase II study
  • OLGA: Capecitabine and bevacizumab with radiotherapy after 3-6 months chemotherapy for patients with oligometastatic colorectal cancer